LSW Institute Lunch and Learn – Funding Strategies for Life Sciences Companies

Amanda is a recognized, focused and innovative leader in the capital markets and life sciences space.

She advises life sciences and technology companies with respect to corporate finance, SEC reporting and governance matters. Amanda has represented issuers and underwriters in a wide variety of public and private financing transactions, including initial public offerings, follow-on and secondary offerings, SPACs, at-the-market offerings, private investment in public equity (PIPEs), and preferred stock and debt financings.

Amanda also advises late-stage private companies with respect to general corporate governance and liquidity preparation and public companies on corporate and securities law compliance and disclosure matters, including corporate governance best practices, Exchange Act reporting obligations and stock exchange requirements.

Kat is a trusted legal and business advisor to technology-focused companies ranging from early-stage startups to mature, publicly traded corporations. Known for her hands-on approach, Kat provides tailored strategic guidance to her clients, helping them address both immediate challenges and long-term goals.

With extensive experience navigating the full corporate lifecycle, Kat advises clients on all aspects of general corporate and securities law, from formation to seed and venture capital financings through M&A and IPOs. Kat also represents venture capital firms and strategic investors that invest in these companies.

Kat is also active in the broader startup community, serving on the startup advisory board to the Washington Technology Industry Association and contributes to the venture capital data report, the Venture Beacon, in collaboration with Aumni, a J.P. Morgan company.

Kat has been selected in Super Lawyers as a “Rising Star” for nine consecutive years (2013 – 2022).